Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: a retrospective study(WJOG4407GSS)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 08 May 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Jul 2016 Status changed from not yet recruiting to recruiting.
- 17 May 2016 New trial record